as on February 20, 2026 at 7:59 am IST
Day's Low
Day's High
1.60%
Downside
0.25%
Upside
52 Week's Low
52 Week's High
16.45%
Downside
11.37%
Upside
Check Edwards Lifesciences Corp. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$46.3B
EPS (TTM)
2.9532
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
-0.76%
PE Ratio (TTM)
43.6
Industry PE ratio
18.238589743589742
PEG Ratio
4.1293
EBITDA
1.8B
Revenue (TTM)
6.1B
Profit Margin
17.69%
Return On Equity TTM
10.42%
Track how Edwards Lifesciences Corp. P/E has moved over time to understand its valuation trends.
Edwards Lifesciences Corp. in the last 5 years
Lowest (26.71x)
December 31, 2024
Industry (18.24x)
February 20, 2026
Today (43.60x)
February 20, 2026
Highest (52.31x)
December 31, 2021
Today’s Price to Earnings Ratio: 43.60x
Compare market cap, revenue, PE, and other key metrics of Edwards Lifesciences Corp. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $46.3B | -6.39% | 43.6 | 17.69% | |
| BUY | $113.1B | 99.11% | 39.32 | 14.44% | |
| BUY | $144.4B | 53.93% | 44.87 | 12.92% | |
| BUY | $126.3B | -13.9% | 26.69 | 13.00% | |
| BUY | $197.2B | -8.82% | 30.45 | 14.72% |
The Edwards Lifesciences Corp. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Edwards Lifesciences Corp. investment value today
Current value as on today
₹1,10,477
Returns
₹10,477
(+10.48%)
Returns from Edwards Lifesciences Corp. Stock
₹5,635 (+5.64%)
Dollar Returns*
₹4,842 (+4.84%)
Based on 40 analysts
60.00%
Buy
35.00%
Hold
5.00%
Sell
Based on 40 analysts, 60% of analysts recommend a 'BUY' rating for Edwards Lifesciences Corp.. Average target price of $96.5
Get share price movements and forecasts by analysts on Edwards Lifesciences Corp..
What analysts predicted
18.22%UPSIDE
Target Price
$96.5
Current Price
$78.92
Analyzed by
40 Analysts
Target
$96.50
Edwards Lifesciences Corp. target price $96.5, a slight upside of 18.22% compared to current price of $78.92. According to 40 analysts rating.
Search interest for Edwards Lifesciences Corp. Stock has increased by 155% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:155% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 11 February
Wed, 05:30 PM
-Analysts provide mixed ratings for Edwards Lifesciences; average price target rises to $97.62, indicating investor confidence.
Wed, 06:47 PM
-Edwards Lifesciences reports Q4 2025 adjusted EPS of 58 cents, missing estimates; sales rise 13.3% to $1.57 billion.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Revenue Rich
![]()
Edwards Lifesciences Corp. has seen consistent revenue growth over the last six quarters. Their revenue increased from $1.35 billion to $1.56 billion. On average, the company has experienced a quarterly revenue increase of 2.9%.
Price Rise
![]()
In the last 7 days, EW stock has moved up by 4.0%
Against Peers
![]()
In the last 3 years, Boston Scientific Corp. has given 15.1% return, outperforming this stock by 14.6%
Against Peers
![]()
In the last 1 year, Medtronic Plc has given 11.0% return, outperforming this stock by 5.4%
Profit Down
![]()
Edwards Lifesciences Corp. has experienced a decline in net profit for the past six quarters, falling from $3.07 billion to $91.2 million. This represents an average decrease of 36.6% in profit each quarter.
| Organisation | Edwards Lifesciences Corp. |
| Headquarters | One Edwards Way, Irvine, CA, United States, 92614 |
| Industry | Health Technology |
| CEO | Mr. Bernard J. Zovighian |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Mr. Dirksen J. Lehman | Corporate Vice President of Public Affairs |
Mr. Bernard J. Zovighian | CEO & Director |
Mr. Scott B. Ullem | Corporate VP & CFO |
Mr. Daveen Chopra | Corporate Vice President of Transcatheter Mitral & Tricuspid Therapies |
Dr. Todd J. Brinton FACC, M.D. | Corporate VP of Advanced Innovation & Technology and Chief Scientific Officer |
Mr. Mark D. Peterson | Corporate VP & General Counsel |
Mr. Donald E. Bobo Jr. | Corporate Vice President of Strategy & Corporate Development |
Mr. Jean-Luc Lemercier | Corporate Vice President of Japan, Asia Pacific & Greater China |
Mr. Andrew M. Dahl | Principal Accounting Officer, Senior VP & Corporate Controller |
Mr. Snehashish Sarkar | Senior VP, Chief Information & Digital Officer |
Edwards Lifesciences Corp. share price today is $78.92 as on at the close of the market. Edwards Lifesciences Corp. share today touched a day high of $79.12 and a low of $77.66.
Edwards Lifesciences Corp. share touched a 52 week high of $87.89 on and a 52 week low of $65.94 on . Edwards Lifesciences Corp. stock price today i.e. is closed at $78.92,which is 10.21% down from its 52 week high and 19.68% up from its 52 week low.
Edwards Lifesciences Corp. market capitalisation is $0.05T as on .
Indian investors can start investing in Edwards Lifesciences Corp. (EW) shares with as little as ₹91.108 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹911.08 in Edwards Lifesciences Corp. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Edwards Lifesciences Corp. share’s latest price of $78.92 as on February 20, 2026 at 2:29 am IST, you will get 0.1267 shares of Edwards Lifesciences Corp.. Learn more about
fractional shares .
Edwards Lifesciences Corp. stock has given -6.39% share price returns and 25.11% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?